Insights

Independent Third-Party Administrator Saves Groups $5.6M on PBM Contract

Our TPA client delivers initial Rx savings to its groups and taps into Navion’s unmatched year-round clinical support.
Learn More

Inside Navion: Employee Voices – Giorgio Vescera

Meet Giorgio Vascera, Navion’s Senior Director of Consulting and Analytics.
Learn More

Employer Group Saves $1.8M on Specialty Drug Costs

Worked with a specialty vendor to get the pharmaceutical manufacturer to cover specialty medication costs.
Learn More

AlignRx Named Finalist for Best Places to Work in Western New York

AlignRx received an overall score of 95.17 out of 100 based on responses in those six categories.
Learn More

Stay Informed, Stay Ahead: CVS’s Transition from Humira to Biosimilars

Earlier this month, CVS announced a major change to some of their formularies. This includes the removal of Humira, a widely used medication.
Learn More

Spotlight: Featured on Self-Funded with Spencer Podcast

Brian Shonat, Goodroot’s area vice president of business development, recently joined Spencer Smith on the Self-Funded with Spencer podcast
Learn More

Levemir Discontinuation: What You Need to Know

Important update regarding a recent development about Novo Nordisk’s announcement to discontinue Levemir.
Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Clinical Insight

The Rise of Direct-to-Consumer Drug Pricing 

AlignRx is Now Navion